Your browser doesn't support javascript.
loading
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy.
Paller, A S; Siegfried, E C; Simpson, E L; Cork, M J; Lockshin, B; Kosloski, M P; Kamal, M A; Davis, J D; Sun, X; Pirozzi, G; Graham, N M H; Gadkari, A; Eckert, L; Ruddy, M; Bansal, A.
Afiliação
  • Paller AS; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Siegfried EC; Saint Louis University and Cardinal Glennon Children's Hospital, St. Louis, MO, USA.
  • Simpson EL; Oregon Health and Science University, Portland, OR, USA.
  • Cork MJ; University of Sheffield, Sheffield, UK.
  • Lockshin B; Georgetown University, Rockville, MD, USA.
  • Kosloski MP; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Kamal MA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Davis JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Sun X; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Pirozzi G; Sanofi, Bridgewater, NJ, USA.
  • Graham NMH; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Gadkari A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Eckert L; Sanofi, Chilly-Mazarin, France.
  • Ruddy M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
  • Bansal A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
J Eur Acad Dermatol Venereol ; 35(2): 464-475, 2021 Feb.
Article em En | MEDLINE | ID: mdl-32893393

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatite Atópica Idioma: En Ano de publicação: 2021 Tipo de documento: Article